DGAP-News: Themis Beteiligungs-Aktiengesellschaft announces partial sale of existing shares in Dermapharm Holding SE via Accelerated Bookbuilding

Themis Beteiligungs-Aktiengesellschaft, main shareholder in Dermapharm Holding SE, intends to place 5,384,000 shares in Dermapharm Holding SE (ISIN DE000A2GS5D8), corresponding to 10.0% of the outstanding share capital, by way of an Accelerated Bookbuilding, which is to commence immediately following the publication of this release, via Berenberg as Sole Global Coordinator and Sole Bookrunner.